首页|微小核糖核酸-21和微小核糖核酸-431对肺结核病情发展及预后评估价值研究

微小核糖核酸-21和微小核糖核酸-431对肺结核病情发展及预后评估价值研究

扫码查看
目的 分析支气管镜检标本微小核糖核酸(microRNA,miRNA)-21、miRNA-431对肺结核病情发展及预后评估价值.方法 纳入陕西省结核病防治院2022年5月-2023年7月临床收治43例确诊肺结核患者为研究组,纳入同期43例肺炎患者为对照组,研究组中根据肺部病灶肺野数量分级轻度14例、中度19例、重度10例,根据预后情况分为预后不良和预后良好,比较研究组与对照组、研究组内不同病情严重程度以及研究组内不同预后患者miRNA-21、miRNA-431水平,采用logistic多因素分析影响肺结核疾病发展及预后的因素,建立影响肺结核病情发展及预后的预测模型,通过受试者工作特征曲线(receiver operating characteristic curve,ROC)分析模型预测价值.结果 研究组miR-NA-21、miRNA-431水平均显著高于对照组,组间差异统计学意义成立(P<0.05);研究组内,病情严重程度与患者miR-NA-21、miRNA-431水平成正比,且重度肺结核患者miRNA-21、miRNA-431水平显著高于轻度、中度肺结核患者,组间差异有统计学意义(P<0.05);研究组内,预后不良肺结核患者miRNA-21、miRNA-431水平均显著高于预后良好肺结核患者,组间差异有统计学意义(P<0.05);以miRNA-21、miRNA-431表达为自变量,连续变量;将肺结核病情发展及预后作为因变量进行logistic回归分析.结果 显示,miRNA-21、miRNA-431高表达均为肺结核病情发展及预后的影响因素(P<0.05);绘制ROC曲线结果显示,预测模型最佳临界值为0.089 5,miRNA-21、miRNA-431和两项联合的ROC曲线下面积(area under curve,AUC)为 0.614(0.651~0.732)、0.671(0.686~0.811)、0.891(0.787~0.993).结论 肺结核患者 miR-NA-21、miRNA-43 1水平高表达,与病情发展密切相关,在一定程度上可预测肺结核患者预后,联合诊断综合应用价值高,建议临床推广使用.
Evaluation value of miRNA-21 and miRNA-431 in the development and prognosis of pulmonary tuberculosis
Objective To evaluate the value of bronchoscopy specimens'microRNA-21(miRNA-21)and microRNA-431(miRNA-431)in the development and prognosis of pulmonary tuberculosis.Methods A total of 43 confirmed pulmonary tuberculosis patients admitted to Shaanxi Provincial Tuberculosis Prevention Hospital from May 2022 to July 2023 were included as the study group,and 43 healthy volunteers during the same period were included as the control group.In the study group,the severity of lung lesions was classified as mild in 14 cases,moderate in 19 cases,and severe in 10 cases.According to the prognosis,patients were divided into poor prognosis and good prognosis groups.The miRNA-21 and miRNA-431 levels of patients with different disease severity and prognosis in the study group and the control group were compared,and the factors affecting the development and prognosis of tuberculosis were analyzed by logistic multivariate analysis,and a prediction model for the development and prognosis of tuberculosis was established.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of the model.Results The levels of miRNA-21 and miRNA-431 in the study group were significantly higher than those in the control group,and the difference between groups was statistically significant(P<0.05).In the study group,the levels of miRNA-21 and miRNA-431 were positively correlated with the severity of the disease,and the levels in severe pulmonary tuberculosis patients were significantly higher than those in mild and moderate pulmonary tuberculosis patients,with statistically significant differences between the groups(P<0.05).In the study group,the levels of miRNA-21 and miRNA-431 in patients with pulmonary tuberculosis with poor prognosis were significantly higher than those in patients with pulmonary tuberculosis with good prognosis,with statistically significant differences between the groups(P<0.05).Using miRNA-21 and miRNA-431 expression as independent variables,and the development and prognosis of pulmonary tuberculosis as dependent variables,logistic regression analysis was performed.The results showed that the high expression of miRNA-21 and miRNA-431 were both influential factors for the development and prognosis of pulmonary tuberculosis(P<0.05).The ROC curve analysis showed that the optimal cutoff value of the prediction model was 0.0895,and the area under the curve(AUC)of miRNA-21,miRNA-431 and combined were 0.614(0.651-0.732),0.671(0.686-0.811),and 0.891(0.787-0.993).Conclusions The high expression levels of miRNA-21 and miRNA-431 in patients with tuberculosis are closely related to the development of the disease and can predict the prognosis of patients with tuberculosis to a certain extent.The comprehensive application value of combined diagnosis is high,and it is recommended to promote clinical use.

miRNA-21miRNA-431pulmonary tuberculosisdisease progressionprognosis assessment

卢琼、董珍、王婉如

展开 >

陕西省结核病防治院(陕西省第五人民医院),陕西西安 710100

微小核糖核酸-21 微小核糖核酸-431 肺结核 病情发展 预后评估

陕西省卫生健康科研基金

2018D046

2024

中国热带医学
中华预防医学会,海南疾病预防控制中心

中国热带医学

CSTPCD北大核心
影响因子:0.722
ISSN:1009-9727
年,卷(期):2024.24(2)
  • 21